Erika Covi
Erika Covi publishes mostly in Economics and Econometrics, Oncology and Physiology, on topics such as CAR-T cell therapy research, Biomedical Ethics and Regulation and Innovation Policy and R&D.
- World rank
- #574,954 of 1,633,909 ranked researchers
- Rank in Germany
- #34,149 of 86,443
- Works
- 16
- Citations
- 17
- Citations per work
- 1.1
What does Erika Covi research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Economics and Econometrics33% of their works
- 2Oncology33% of their works
- 3Physiology33% of their works
Research topics
Which keywords describe Erika Covi's research?
The keywords of their largest research topics: CAR T Cells, Chimeric Antigen Receptor, Clinical Trials, Private R&D, R&D Subsidies and Stem Cell Regulation.
Size is their works in the topics tagged with each word, from their 3 largest topics. Each links to the topic it comes from most.
All 6 words, with their numbers
- CAR T Cells11 topic
- Chimeric Antigen Receptor11 topic
- Clinical Trials11 topic
- Private R&D11 topic
- R&D Subsidies11 topic
- Stem Cell Regulation11 topic
Where does Erika Covi work?
Erika Covi's main affiliation in the publication record is NaMLab (Germany), Germany.
How many publications and citations does Erika Covi have?
Science Explorer counts 16 works and 17 citations for Erika Covi, ranking #574,954 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.